MediPress Health-Limited Partnership (TLV:MPRS)
Israel · Delayed Price · Currency is ILS · Price in ILA 63.50
-0.10 (-0.16%)
At close: Jan 27, 2026
TLV:MPRS Market Cap
TLV:MPRS has a market cap or net worth of 9.53 million as of January 30, 2026. Its market cap has decreased by -43.61% in one year.
Market Cap
9.53M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
63.50
Market Cap Chart
Since December 30, 2021, TLV:MPRS's market cap has decreased from 29.15M to 9.53M, a decrease of -67.30%. That is a compound annual growth rate of -23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 9.53M | 28.28% |
| Dec 31, 2025 | 7.43M | -30.87% |
| Dec 31, 2024 | 10.75M | -22.59% |
| Dec 31, 2023 | 13.89M | 43.63% |
| Dec 22, 2022 | 9.67M | -66.84% |
| Dec 30, 2021 | 29.15M | - |
| Dec 30, 2021 | 29.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 121.11B |
| Danel (Adir Yeoshua) | 2.80B |
| Kamada | 1.50B |
| BrainsWay | 1.42B |
| Identi Healthcare | 24.55M |
| Bio-View | 23.45M |
| Tikun Olam-Cannbit Pharmaceuticals | 20.56M |
| Purple Biotech | 20.44M |